| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |